20 Aug 2009 07:00
Immunodiagnostic Systems Holdings plc
Holding(s) in Company
Immunodiagnostic Systems Holdings plc ("IDS" or "the Company"), a leading producer of diagnostic testing kits for the clinical and research markets, announces that on 19 August 2009 Nordic Bioscience A/S ("Nordic") disposed of its entire holding in IDS, with the majority of the shares being purchased by Forum Venture Capital GmbH ("Forum"), taking their holding to 24.6%.
Following the purchase of ordinary shares Forum has a direct interest in 6,504,364 voting shares in the Company, representing 24.6% of the issued share capital. Prior to the transaction Forum held 4,221,064 voting shares in IDS.
Prior to the transaction Nordic held 2,783,300 voting shares in IDS. Nordic was the vendor of Nordic Bioscience Diagnostics A/S acquired by IDS in 2007 with the consideration satisfied in cash and 2,783,300 IDS shares.
Enquiries:
| Immunodiagnostic Systems Holdings Plc | Tel: 0191 519 0660 |
| Roger Duggan, CEO | |
| Paul Hailes, Finance Director | |
| Brewin Dolphin Investment Banking | Tel: 0845 213 4730 |
| Andrew Emmott Sean Wyndham-Quin | |
| Walbrook PR Ltd | Tel: 020 7933 8787 |
| Paul McManus | Mob: 07980 541 893 |
| paul.mcmanus@walbrookpr.com |